The US Surgical Robots Market was valued at $4971.2 Million in 2025 and projected to reach to $10246.5 Million by 2030, representing a compound annual growth rate of 15.6%. The US surgical robots market is poised for sustained growth through 2030, driven by increasing surgeon adoption, expanding procedural applications, and growing patient demand for minimally invasive options.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US surgical robots market is valued at $4,971.2 million in 2025 and is projected to reach $10,246.5 million by 2030, representing a robust 15.6% CAGR over the forecast period.
The US benefits from world-class healthcare infrastructure with high hospital density and significant capital investment in surgical technology, enabling rapid adoption of robotic-assisted surgical systems across major medical centers.
US hospitals and surgical centers are increasingly prioritizing minimally invasive procedures, driving demand for robotic-assisted surgery solutions that offer improved precision, reduced recovery times, and better patient outcomes.
The US market features intense competition among leading robotic surgery manufacturers, spurring innovation, product development, and strategic partnerships that accelerate technology advancement and market penetration.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ORTHOPEDIC ROBOTIC SYSTEMS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 14.7% from 2025 to 2030 |
| Largest Segment | HOSPITALS & CLINICS (End User) |
| Market Size Base Year (Billions) | ~USD 13.67 (2025) |
| Revenue Forecast (Billions) | ~USD 27.14 (2030) |
| Segments Covered | Offering, Type, Application, End User |
4 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 1087.55 | 1202.99 | 1331.81 | 1475.72 | 1636.63 | 1816.72 | 2018.49 | 2244.76 | 11 |
| HOSPITALS & CLINICS | 5460.3 | 6290.4 | 7252.9 | 8369.9 | 9667.6 | 11176.6 | 12933 | 14979.6 | 15.6 |
| TOTAL | 6547.8 | 7493.4 | 8584.7 | 9845.6 | 11304.2 | 12993.3 | 14951.4 | 17224.4 | 14.9 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TRANSENTERIX | United States | Private Company | Robotic Systems (Laparoscopy, Orthopedic),Instruments & Accessories,Services, |
| TENET HEALTHCARE CORPORATION | United States | Public Company | Instruments & Accessories,Robotic Systems (Laparoscopy),Robotic Systems (Orthopedic), |
| STRYKER | United States | Public Company | Robotic Systems (Orthopedic),Instruments & Accessories,Services, |
| ZIMMER BIOMET | United States | Public Company | Robotic Systems - Orthopedic,Instruments & Accessories,Services, |
| MEDTRONIC | Ireland | Public Company | Instruments & Accessories,Robotic Systems - Laparoscopy,Robotic Systems - Orthopedic, |
| SMITH+NEPHEW | United Kingdom | Public Company | Robotic Systems – Orthopedic,Instruments & Accessories,Services, |
| ASENSUS SURGICAL US, INC. | United States | Subsidiary | Instruments & Accessories,Robotic Systems (Laparoscopy),Robotic Systems (Orthopedic), |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Instruments & Accessories,Robotic Systems (Laparoscopy),Robotic Systems (Orthopedic), |
| RENISHAW PLC | United Kingdom | Public Company | Robotic Systems (Neurosurgical / Stereotactic),Instruments & Accessories,Services & Software, |
| GLOBUS MEDICAL | United States | Public Company | Instruments & Accessories,Robotic Systems - Orthopedic,Robotic Systems - Laparoscopy, |
| JOHNSON & JOHNSON | United States | Public Company | Instruments & Accessories,Robotic Systems (Laparoscopy, Orthopedic),Services, |
| CORIN GROUP | United Kingdom | Private Company | Robotic Systems – Orthopedic (Apollo, ApolloKnee),Instruments & Accessories,Services, |
TRANSENTERIX is a United States-based private company with 208 employees operating in the medical device sector.
TENET HEALTHCARE CORPORATION is a major public healthcare provider founded in 1967 and headquartered in the United States, operating with approximately 88,500 employees across its healthcare facilities and services.
STRYKER is a publicly traded medical technology company founded in 1941 and headquartered in the United States, with approximately 56,000 employees serving the orthopedic and surgical markets.
ZIMMER BIOMET is a public company founded in 1927 and based in the United States, employing 17,000 people as a leading manufacturer of orthopedic and musculoskeletal healthcare products.
MEDTRONIC is a publicly traded global medical technology company founded in 1949 and headquartered in Ireland, with approximately 95,000 employees developing and manufacturing medical devices and therapies.
SMITH+NEPHEW is a publicly traded British medical device company founded in 1856, employing 16,988 people and specializing in orthopedic reconstruction, advanced wound management, and sports medicine.
ASENSUS SURGICAL US, INC. is a subsidiary company based in the United States operating in the surgical technology sector.
SIEMENS HEALTHINEERS AG is a publicly traded German healthcare technology company founded in 1896, employing 72,369 people and providing diagnostic imaging, laboratory diagnostics, and point-of-care testing solutions.
RENISHAW PLC is a publicly traded British precision engineering company founded in 1973, employing 4,975 people and specializing in metrology, healthcare, and industrial automation technologies.
GLOBUS MEDICAL is a publicly traded United States medical device company founded in 2003, employing 6,000 people and focusing on musculoskeletal healthcare solutions.
JOHNSON & JOHNSON is a publicly traded American multinational healthcare company founded in 1886, employing 138,200 people and operating across pharmaceuticals, medical devices, and consumer health sectors.
CORIN GROUP is a private British orthopedic medical device company founded in 1985, employing 324 people and specializing in joint reconstruction solutions.
The US surgical robots market is valued at $4,971.2 million in 2025 and is projected to reach $10,246.5 million by 2030.
The US surgical robots market is expected to grow at a compound annual growth rate (CAGR) of 15.6% from 2025 to 2030.
Key drivers include advanced healthcare infrastructure, favorable reimbursement policies, rising demand for minimally invasive procedures, and continuous technological innovation in the US market.
US hospitals invest in surgical robots to enhance surgical precision, reduce patient recovery times, improve clinical outcomes, and maintain competitive advantage in the healthcare market.
The US market grows at 15.6% CAGR, outpacing the global market CAGR of 14.7%, reflecting the US's mature healthcare infrastructure and strong adoption of robotic-assisted surgical technologies.
This study involved four major activities in estimating the current size of the surgical robots market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was employed to identify and collect information relevant to the comprehensive, technical, market-oriented, and commercial study of the surgical robots market. It was also used to obtain important information about key players, market classification, and segmentation according to industry trends, as well as key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the surgical robots market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the surgical robots market is provided below:
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Other include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global surgical robots market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping was conducted for the respective business segments and subsegments for the major players. Also, the global surgical robots market was split into various segments and subsegments based on:
The above-mentioned data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets, and is presented in this report.

After arriving at the overall size of the global surgical robots market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Surgical robots are the latest medicinal gadgets developed to aid surgeons in carrying out complicated surgeries with more control, precision, and flexibility than they would have achieved had they operated using traditional means. Such systems normally consist of robotic arms equipped with specialized equipment and high-definition cameras, which are manipulated by a surgeon through a console. Surgical robots facilitate minimal invasion of surgery and reduce recovery time of patients, hence minimizing problems and optimizing the overall surgical outcome.
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Surgical Robots Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report